Non-ownership Filings
| Imfinzi approved in US for limited-stage SCLC | Dec. 05, 2024 |
| Block listing Interim Review | Dec. 02, 2024 |
| Total Voting Rights | Dec. 02, 2024 |
| Truqap improved rPFS in advanced prostate cancer | Nov. 25, 2024 |
| Tagrisso recommended for EU approval - LAURA | Nov. 18, 2024 |
| AstraZeneca invests $3.5 billion in US | Nov. 12, 2024 |
| KOMET Phase III trial met primary endpoint | Nov. 12, 2024 |
Ownership Update Filings
| Director/PDMR Shareholding | Nov. 20, 2024 |
| Director/PDMR Shareholding | Nov. 15, 2024 |
| Director/PDMR Shareholding | Nov. 15, 2024 |
| Director/PDMR Shareholding | Nov. 13, 2024 |
| Director/PDMR Shareholding | Jun. 12, 2024 |
| Director/PDMR Shareholding | May. 15, 2024 |
| Director/PDMR Shareholding | Mar. 12, 2024 |